Producer
Musashino Chemical Laboratory, Ltd.
Japanese pharmaceutical-grade lactic acid and lactate manufacturer (HQ Tokyo; specialty chemical division); supplies pharmaceutical-grade sodium lactate to Japanese IV fluid manufacturers (Otsuka Pharmaceutical, Terumo). Musashino is a key supplier in the Japanese pharmaceutical lactic acid market, which is largely self-contained (Japanese IV fluid manufacturers prefer domestic suppliers for audit and regulatory compliance reasons). The Japanese IV fluid market has a distinct supply chain from European and North American markets — distinct raw materials, different suppliers, and stricter regulatory expectations from PMDA (Japan's FDA equivalent).
1
Inputs supplied
1
Goods downstream
0
Facilities
0
Stories
What they make
1 input Musashino Chemical Laboratory, Ltd. supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Musashino Chemical Laboratory, Ltd. makes, pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
Pharmaceutical Sodium Lactate (Japan)
55%Lactic Acid & Lactates (Food & Industrial)
30%Specialty Chemical Products
15%
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Chokepoint2023
Japan's pharmaceutical sodium lactate supply chain is almost entirely domestically sourced -- Musashino and similar Japanese suppliers serve Otsuka Pharmaceutical and Terumo, who manufacture the IV solutions used in Japanese hospitals. PMDA's regulatory framework has created a market segmentation: Japanese IV manufacturers cannot easily substitute European Corbion or Belgian Galactic sodium lactate for Japanese-supplied Musashino product without regulatory re-filing and PMDA inspection of new suppliers. This protects Musashino's market position but also means that if Musashino faces a major production disruption (earthquake at its Tokyo facilities, contamination event, or financial distress), Japanese IV manufacturers cannot quickly source replacement pharmaceutical sodium lactate from European or North American producers. Japan's IV solution supply chain self-containment -- a feature in normal times -- becomes a vulnerability when the domestic supply node is disrupted.
Pharmaceuticals and Medical Devices Agency (PMDA) ↗Origin2023
Musashino Chemical Laboratory is a Japanese specialty fermentation chemical company that exists in a market structure characteristic of Japanese pharmaceutical supply: PMDA (the Pharmaceuticals and Medical Devices Agency, Japan's FDA equivalent) requires that pharmaceutical ingredients used in Japanese IV solutions be manufactured under Japanese GMP or at PMDA-inspected foreign facilities with demonstrated equivalence. This regulatory preference, combined with Japanese pharmaceutical companies' preference for domestic suppliers that can be audited by Japanese quality assurance teams, has created a largely self-contained Japanese pharmaceutical lactic acid market. Musashino, along with a small number of Japanese domestic suppliers, fills this role for Otsuka Pharmaceutical (the largest Japanese IV fluid company) and Terumo (a major Japanese medical device and IV solutions company). The same Japanese regulatory environment that protected domestic suppliers has made the Japanese IV solution supply chain relatively insulated from European or North American supply disruptions -- and relatively insulated from global competition, maintaining domestic supplier positions.
Musashino Chemical Laboratory, Ltd. ↗